Laxido

Polyethylene glycol 3350 with electrolytes, the active ingredient in Laxido, is an osmotic laxative presented as a powder for oral solution for oral use. It is used to relieve constipation and to cleanse the bowel before diagnostic procedures such as colonoscopy.

GNH USA supplies Laxido as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Laxido, an osmotic laxative, is employed in conditions requiring increased intestinal water content and bowel evacuation. - Constipation: softens stool and promotes regular bowel movements in patients with functional constipation. - Bowel preparation for colonoscopy: clears the colon to allow clear visualization during colonoscopic examination. - Diagnostic colonoscopy: provides effective bowel cleansing to facilitate accurate diagnostic assessment.

Laxido may be associated with a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild stomach upset that usually resolves without intervention. - Abdominal bloating: feeling of fullness due to retained gas. - Flatulence: increased intestinal gas leading to passing of wind. - Diarrhea: loose stools occurring when excess water remains in the colon. - Electrolyte imbalance: mild changes in sodium or potassium levels. - Abdominal pain: cramping discomfort in the lower abdomen.

Serious or Rare Side Effects: - Severe dehydration: marked loss of body fluids requiring medical attention. - Significant electrolyte disturbances: dangerous shifts in sodium, potassium, or chloride. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Colonic perforation: rare tearing of the colon wall, a medical emergency.

Before initiating Laxido, certain precautions should be considered to ensure safe use. - Renal function assessment: evaluate kidney function, especially in patients with chronic kidney disease. - Electrolyte monitoring: check serum electrolytes prior to and during therapy in at‑risk individuals. - Bowel obstruction caution: avoid use in patients with known or suspected mechanical obstruction. - Hypersensitivity warning: discontinue if signs of allergic reaction appear. - Dose adjustment in elderly: consider lower initial dose for older adults. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Laxido can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Concurrent osmotic laxatives: additive effect may cause severe diarrhea and electrolyte loss. - Loop diuretics: combined use can exacerbate electrolyte depletion. - Lithium therapy: altered lithium clearance may increase risk of toxicity.

Moderate Interactions (Monitor Closely): - Antacids containing magnesium: may increase gastrointestinal side effects. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): potential impact on renal function and electrolytes. - ACE inhibitors: monitor for additive effects on potassium levels.